HOME >> MEDICINE >> NEWS
Popular anti-epileptic drug also effective in controlling debilitating symptom of multiple sclerosis

A study published in the December issue of Archives of Neurology and currently available online shows that levetiracetam reduced phasic spasticity, which is marked by spasms and painful muscle cramps, in 100 percent of patients in a small clinical study.

"It's amazing how many MS patients can't walk, can't move, and you treat their spasticity and they're fine," said Dr. Kathleen Hawker, assistant professor of neurology at UT Southwestern and lead author of the study. "What's nice about these drugs is that they also work for nerve pain, which in turn improves the patient's mood, so we can use one drug for three things instead of prescribing pain killers and antidepressants in addition to the spasticity therapies."

Spasticity is often seen in patients with MS and amyotrophic lateral sclerosis (ALS), as well as after a stroke or spinal-cord injury. It can lead to loss of balance, increased risk of falls, pain, fatigue, and walking difficulties.

Drugs currently used to treat spasticity may cause memory problems, weakness and lethargy in some patients.

"We're trying to look at medicines that can be used for multiple symptoms so we don't get into a lot of drug interactions," Dr. Hawker said. "If we can get the same results with a better-tolerated drug, that's great for our patients."

Researchers examined the histories of 11 patients treated with levetiracetam between January 2001 and June 2002 for MS-related spasticity at Southwestern Medical Center. The patients were treated with levetiracetam for one to four months, with dosages starting at 250 milligrams per day and increasing to 3,000 mg per day. Researchers found that leviteracetam decreased phasic spasticity in patients taking the drug alone as well as in those who took it in combination with other therapies for spasticity. Tonic spasticity, which produces stiffness, did not improve. Overall, the clinical investigators found the side effects of levetiracetam to be gener
'"/>

Contact: Rachel Horton
rachel.horton@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
15-Dec-2003


Page: 1 2

Related medicine news :

1. Popular chewing gum eliminates bacteria that cause bad breath
2. Popular drug for chest pain may promote blood vessel damage
3. Popular long-acting contraceptive linked to vascular dysfunction
4. Popular asthma drug inadequate when used alone, new study shows
5. Popular herbal remedy fails effectiveness test for tinnitus
6. Popular notions about breast cancer-psychology link challenged
7. Sexually Oriented Internet Sites Are Popular And Non-Problematic For Most People, But Pose Risks For Some
8. UCSF Study Finds Popular Blood Thinner Does Not Weaken Bones
9. Survey Finds Increasing Popularity Of Acute Stroke Teams In U.S. Hospitals
10. Strategy effective against drug resistant tuberculosis
11. Study shows patch therapy may be as effective as oral medications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... February 20, 2017 , ... A new ... women are called back for additional examinations without sacrificing cancer detection, according to ... 2011, the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for ...
(Date:2/20/2017)... (PRWEB) , ... February 21, 2017 , ... Nancy ... offering readers a way to “ Getting Over the Bump in the Road ” ... and lessons learned on how to cope with the ups and downs experienced by ...
(Date:2/20/2017)... ... ... Silverado today is pleased to announce that it has entered into a management ... Alexandria, Virginia. The new community is expected to open its doors in the first ... three-story community with underground parking – located on King Street –will serve 66 people ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... 213-8818 , Orbita, Inc., a leading provider of innovative software for connected home ... patient engagement and optimizing care journey management for home healthcare. , Built ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... a cloud-based self-service technology that runs on the Posiflex XT-series of touch screen ... during HIMSS17 in Orlando, Florida. The terminal provider Posiflex is helping ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017 Cognitive Computing for ... is allowing a previously unattainable level of personalized ... this ability, it is anticipated that the Global ... Billion by 2022. The growth of the market ... computing platforms, rising installation of cognitive computing software ...
(Date:2/21/2017)... Feb. 21, 2017  /PR Newswire/ -- UBM Medica,s ... announce the launch of Modern Retina ( ... retina specialists. Built upon the success of ... on the latest innovations in the areas of retinal ... management. By meeting current informational needs and filling existing ...
(Date:2/21/2017)... Scientists From Two Companies to Accelerate Development ... ... STEER, creator of advanced materials platform technologies that effectively ... pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, today announced a ... , a leading science & technology company, on ...
Breaking Medicine Technology:
Cached News: